Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease

Author(s): Ban-Feng Ruan, Xiao-Qin Lu, Jie Song, Hai-Liang Zhu

Journal Name: Current Medicinal Chemistry

Volume 19 , Issue 24 , 2012

Become EABM
Become Reviewer
Call for Editor


Resveratrol (3,5,4'-trans-trihydroxystilbene) is a naturally occurring phytoalexin that is found in medicinal plants, grape skin, peanuts and red wine. Resveratrol exhibits a remarkable range of biological activities, including anticancer activity, antitubulin activity, anti-cardiovascular disease activity, etc. Several other natural products are structurally similar to resveratrol and also present in food. In addition, a series of resveratrol derivatives have been synthesized by the addition of defined functional groups to increase the potency or enhance the activity of specific properties of resveratrol. These resveratrol derivatives might provide promising functions as cardiovascular disease chemopreventive agents. In this review, we will attempt to summarize the main developments of resveratrol derivatives in cardiovascular disease and the main developments have occurred in derivatives of resveratrol’s structure-activity relationship and cardiovascular disease over the last couple of decades.

Keywords: Cardiovascular disease, reactive oxygen species, apoptosis, SIRT1, AMPK, Akt, derivatives of resveratrol, structure-activity relationship, structure-activity, relationship, phytoalexin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 06 August, 2012
Page: [4175 - 4183]
Pages: 9
DOI: 10.2174/092986712802430054
Price: $65

Article Metrics

PDF: 19